D-0078-2023 Class II Terminated
FDA drug recall D-0078-2023 was initiated by OurPharma LLC on Nov 29, 2022 and is designated Class II. Reason for recall: Underfilled units. The recall status is terminated (terminated Sep 20, 2024). Affected quantity: 691 cassettes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 21, 2022
- Initiation Date
- Nov 29, 2022
- Termination Date
- Sep 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 691 cassettes
Product description
FentaNYL Citrate 2.5 mg/50 mL (50mcg/ml) Injection Solution, Preservative Free, Single Use 50 ml Cassette, Rx Only, Repackaged by OurPharma, LLC. 2512 S. City Lake Rd. Fayetteville, AR 72701, 1-833-290-2654, NDC 73013-001-01
Reason for recall
Underfilled units.
Distribution pattern
MO
Code information
Lots: 100122060007 Exp. 12/17/2022; 100122060008 Exp. 12/18/2022; 100122070002 Exp. 01/09/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0078-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026